# COVID-19 Survival - The COVIVA Study

> **NCT04366765** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 1325 (actual)

## Conditions studied

- COVID-19
- SARS-CoV 2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04366765
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-19
- **Primary completion:** 2021-01-05
- **Final completion:** 2021-06-30
- **Target enrollment:** 1325 (ACTUAL)
- **Last updated:** 2021-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04366765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04366765, "COVID-19 Survival - The COVIVA Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04366765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*